Effect of anesthesia carrier gas on in vivo circulation times of ultrasound microbubble contrast agents in rats.
OBJECTIVE
Microbubble contrast agents are currently implemented in a variety of both clinical and preclinical ultrasound imaging studies. The therapeutic and diagnostic capabilities of these contrast agents are limited by their short in-vivo lifetimes, and research to lengthen their circulation times is on going. In this manuscript, observations are presented from a controlled experiment performed to evaluate differences in circulation times for lipid shelled perfluorocarbon-filled contrast agents circulating within rodents as a function of inhaled anesthesia carrier gas.


METHODS
The effects of two common anesthesia carrier gas selections - pure oxygen and medical air were observed within five rats. Contrast agent persistence within the kidney was measured and compared for oxygen and air anesthesia carrier gas for six bolus contrast injections in each animal. Simulations were performed to examine microbubble behavior with changes in external environment gases.


RESULTS
A statistically significant extension of contrast circulation time was observed for animals breathing medical air compared to breathing pure oxygen. Simulations support experimental observations and indicate that enhanced contrast persistence may be explained by reduced ventilation/perfusion mismatch and classical diffusion, in which nitrogen plays a key role by contributing to the volume and diluting other gas species in the microbubble gas core.


CONCLUSIONS
Using medical air in place of oxygen as the carrier gas for isoflurane anesthesia can increase the circulation lifetime of ultrasound microbubble contrast agents.
Joint Department of Biomedical Engineering, University of North Carolina and North Carolina State University, Chapel Hill, NC 27599, USA.
Lee
L
Mullin
Ryan
R
Gessner
James
J
Kwan
Mehmet
M
Kaya
Mark A
MA
Borden
Paul A
PA
Dayton
D000388:Air; D018685:Anesthetics, Inhalation; D000818:Animals; D003287:Contrast Media / Q000737:chemistry / Q000493:pharmacokinetics*; D003952:Diagnostic Imaging / Q000379:methods; D005466:Fluorocarbons; D005740:Gases / Q000494:pharmacology*; D008055:Lipids; D045423:Microbubbles; D051381:Rats; D014463:Ultrasonography / Q000379:methods*
D018685:Anesthetics, Inhalation; D003287:Contrast Media; D005466:Fluorocarbons; D005740:Gases; D008055:Lipids
Artif Cells Blood Substit Immobil Biotechnol. 2005;33(1):47-63
15768565
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1117-36
18486270
Radiology. 2003 Nov;229(2):439-46
14526091
Neurol Res. 1997 Apr;19(2):139-44
9175142
Curr Cardiol Rep. 2008 May;10(3):233-9
18489868
Langmuir. 2008 Mar 4;24(5):1745-9
18205422
Langmuir. 2010 May 4;26(9):6542-8
20067292
Langmuir. 2004 Mar 30;20(7):2567-78
15835125
J Endourol. 2008 Apr;22(4):795-802
18366315
Circulation. 2007 Jan 23;115(3):345-52
17210843
Ultrasound Med Biol. 2009 Aug;35(8):1385-96
19616160
Curr Pharm Biotechnol. 2007 Dec;8(6):355-61
18289044
IEEE Trans Ultrason Ferroelectr Freq Control. 2004 Jul;51(7):822-31
15301001
Radiology. 2008 Sep;248(3):936-44
18710985
Ultrasound Med Biol. 1998 Jun;24(5):751-60
9695278
Ultrasonics. 2000 Nov;38(10):969-77
11106009
Annu Rev Biomed Eng. 2007;9:415-47
17651012
Vet J. 2007 Nov;174(3):501-12
17412620
IEEE Trans Ultrason Ferroelectr Freq Control. 2005 Nov;52(11):1992-2002
16422411
Hepatol Res. 2007 Jun;37(6):464-72
17539818
Contrast Media Mol Imaging. 2008 Jan-Feb;3(1):9-18
18335479
J Am Soc Echocardiogr. 1996 Jul-Aug;9(4):442-51
8827627
Mol Imaging. 2006 Jul;5(3):139-47
16954028
IEEE Trans Ultrason Ferroelectr Freq Control. 2001 Jan;48(1):232-48
11367791
Ultrasound Med Biol. 1989;15(4):319-33
2669297
Eur J Radiol. 2006 Dec;60(3):324-30
16938418
Echocardiography. 2000 Aug;17(6 Pt 2):S11-6
11058234
Front Biosci. 2007 Sep 01;12:5124-42
17569635
J Appl Physiol (1985). 1994 Dec;77(6):2874-8
7896635
Biotechnol Prog. 2009 Jul-Aug;25(4):938-45
19455647
Ultrasound Med Biol. 1998 Jun;24(5):739-49
9695277
Invest Radiol. 1998 Dec;33(12):871-9
9851821